Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-25-014262
Filing Date
2025-04-16
Accepted
2025-04-16 20:58:47
Documents
2
Period of Report
2025-04-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3769
2 EXHIBIT 24 ef20047515_ex24.htm EX-24 13377
  Complete submission text file 0001140361-25-014262.txt   18689
Mailing Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER SUITE 300 PRINCETON NJ 08540 609-322-1602
Grace Therapeutics, Inc. (Issuer) CIK: 0001444192 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address
D'Andrea Carrie (Reporting) CIK: 0001977969 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35776 | Film No.: 25844019